Activities of amphotericin B, fluconazole and voriconazole against
INTRODUCTION SUSCEPTIBILITY OF CANDIDA BLOODSTREAM ISOLATES
A progressive increase in the frequency of candidemia has been observed, particularly among patients receiving antibiotics, immunosuppressive therapy, or parenteral nutrition, as well as among patients exposed to invasive medical procedures such as intravascular catheter, hemodialysis and abdominal surgery (1) (2) (3) .
Candidemia have been associated with significant mortality, especially among critically ill patients.
The attributable mortality of candidemia has been estimated at 25-38%. In addition, an increase of 30 days in the length of hospital stay among patients surviving these infections has been demonstrated.
The economic impact of these infections is also important (3) (4) (5) (6) .
Although Candida albicans is still considered the most frequently isolated species of candidemic patients, the emergence of non-albicans Candida species is clearly a concern. The resistance of nonalbicans Candida isolates to currently available antifungal drugs represents a major challenge for future empirical therapeutic and prophylactic strategies. Therefore, species directed therapy should be administered for fungemia according to the species identified and its antifungal susceptibility pattern (1, 3) .
Candida species have various degrees of susceptibility to frequently used antifungal drugs. For instance, Candida lusitaniae is relatively resistant to amphotericin B, C. krusei is intrinsically resistant to fluconazole, C. glabrata is less susceptible or has a higher MICs to it than other Candida species.
This phenomenon illustrates the importance of identification and surveillance of Candida species in the clinical settings (7). 
Conclusion:
Voriconazole and amphotericin B were active in-vitro against yeasts. As antifungal drug resistance may become more frequent, it is increasingly important to evaluate current antifungal susceptibility profiles of fungal pathogens. 
MATERIALS and METHODS

Candida Isolation and Identification
This study was designed in Mycology Laboratory, 
RESULTS
A total of 90 Candida spp. were isolated from clinical blood samples obtained from patients hospitalized. The most species isolated was C.
albicans followed by C. tropicalis, C. parapsilosis, C. glabrata, C. krusei and C. kefyr (Table 1) . Table 2 to antifungals in the literature (9, 18, 23) . In the present study, 3.3% of Candida isolates were C. kefyr of which were sensitive fluconazole, voriconazole and amphotericin B.
In our study, all C. parapsilosis isolates were susceptible to three antifungals and one C. tropicalis 
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